指南与共识皮肤肿瘤

欧洲皮肤病论坛指南:局部光动力疗法(2019)第一部分——治疗实施与已确立适应证:光化性角化病、鲍温病及基底细胞癌

European Dermatology Forum guidelines on topical photodynamic therapy 2019 Part 1: treatment delivery and established indications - actinic keratoses, Bowen's disease and basal cell carcinomas.
指南 / 共识 · J Eur Acad Dermatol Venereol · 2019-01-01

本指南由欧洲皮肤病论坛指南委员会光动力治疗(PDT)专家组制定,基于当前已发表证据,针对局部PDT在皮肤科已批准及新兴适应证的应用给出共识性专家推荐。第一部分聚焦治疗实施及已确立适应证:光化性角化病、鲍温病(原位鳞状细胞癌)及浅表型和某些薄型基底细胞癌。指南指出标准方案PDT的复发率通常与现有疗法相当,但对结节型基底细胞癌劣于手术;日光PDT广泛用于光化性角化病且疼痛轻微,传统红光PDT用于其他浅表皮肤癌及日光疗法不可行的光化性角化病。

要点

  • 局部PDT适用于光化性角化病、鲍温病及浅表型和某些薄型基底细胞癌。
  • 标准方案PDT复发率通常与现有疗法相当,但结节型基底细胞癌劣于手术。
  • 日光PDT广泛用于光化性角化病,疼痛无或轻微且患者偏好。

核心结论

  • 局部PDT是光化性角化病、鲍温病及浅表型和某些薄型基底细胞癌广泛认可的疗法。
  • 标准方案PDT的复发率通常与现有疗法相当,但对结节型基底细胞癌劣于手术。
  • PDT可作病灶性和区域治疗,并可能延迟或减少新病灶的发生。

研究设计与样本

  • 本指南由欧洲皮肤病论坛指南委员会PDT专家组制定,分两部分发表,基于当前已发表证据给出共识性专家推荐。

主要发现

  • 标准方案PDT的复发率通常与现有疗法相当,但对结节型基底细胞癌劣于手术。
  • 日光PDT广泛用于光化性角化病,传统红光PDT(通常封包3小时后)用于其他浅表皮肤癌及日光疗法不可行的光化性角化病。
  • PDT耐受性良好,但传统方案相关不适可能需要疼痛缓解措施;日光PDT疼痛无或轻微且患者偏好。
  • 有新兴文献探讨增强传统PDT方案或将PDT与其他治疗联合以提高应答率。

关键数值与推荐

  • 局部PDT适用于光化性角化病、鲍温病(原位鳞状细胞癌)、浅表型和某些薄型基底细胞癌。
  • 日光PDT广泛用于光化性角化病的治疗。
  • 传统红光PDT通常在封包3小时后进行,用于其他浅表皮肤癌适应证及日光疗法不可行的光化性角化病。

临床怎么用

  • 对光化性角化病可优先考虑日光PDT,因其疼痛无或轻微且患者偏好。
  • 对浅表型和某些薄型基底细胞癌可采用传统红光PDT,但结节型基底细胞癌应知晓其逊于手术。
  • 传统PDT方案相关不适时可采取疼痛缓解措施。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Topical photodynamic therapy (PDT) is a widely approved therapy for actinic keratoses, Bowen's disease (squamous cell carcinoma in situ), superficial and certain thin basal cell carcinomas. Recurrence rates when standard treatment protocols are used are typically equivalent to existing therapies, although inferior to surgery for nodular basal cell carcinoma. PDT can be used both as lesional and field therapies and has the potential to delay/reduce the development of new lesions. A protocol using daylight to treat actinic keratoses is widely practised, with conventional PDT using a red light after typically a 3-h period of occlusion employed for other superficial skin cancer indications as well as for actinic keratoses when daylight therapy is not feasible. PDT is a well-tolerated therapy although discomfort associated with conventional protocol may require pain-reduction measures. PDT using daylight is associated with no or minimal pain and preferred by patient. There is an emerging literature on enhancing conventional PDT protocols or combined PDT with another treatment to increase response rates. This guideline, published over two parts, considers all current approved and emerging indications for the use of topical PDT in dermatology, prepared by the PDT subgroup of the European Dermatology Forum guidelines committee. It presents consensual expert recommendations reflecting current published evidence.

来源:J Eur Acad Dermatol Venereol,查看原文。版权归原作者所有。

引用

  1. Morton CA, Szeimies RM, Basset-Seguin N, et al. European Dermatology Forum guidelines on topical photodynamic therapy 2019 Part 1: treatment delivery and established indications - actinic keratoses, Bowen's disease and basal cell carcinomas. J Eur Acad Dermatol Venereol. 2019. PMID: 31779042. doi:10.1111/jdv.16017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。